Prospective bone ultrasound patterns during childhood acute lymphoblastic leukemia treatment

被引:14
|
作者
Mussa, Alessandro [1 ]
Bertorello, Nicoletta [2 ]
Porta, Francesco [1 ]
Galletto, Chiara [2 ]
Nicolosi, Mario Guido [3 ]
Manicone, Rosaria [2 ]
Corrias, Andrea [1 ]
Fagioli, Franca [2 ]
机构
[1] Univ Turin, Regina Margherita Children Hosp, Dept Pediat Endocrinol & Diabetol, Div Pediat Endocrinol, I-10126 Turin, Italy
[2] Univ Turin, Dept Pediat Oncohematol, I-10126 Turin, Italy
[3] St Anna Hosp, Dept Gynecol & Obstet, Turin, Italy
关键词
Pediatrics; Childhood leukemia; Bone complications; Quantitative ultrasound; Fractures; PHALANGEAL QUANTITATIVE ULTRASOUND; YOUNG-ADULT SURVIVORS; HUMAN FINGER PHALANGES; MINERAL DENSITY; FRACTURE RISK; CHILDREN; TURNOVER; PROPAGATION; GEOMETRY; GROWTH;
D O I
10.1016/j.bone.2009.12.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Bone impairment is a well-known complication in childhood acute lymphoblastic leukemia (ALL) survivors but less is known about bone dynamics during ALL therapy. We longitudinally assessed by Quantitative Ultrasound (QUS) skeletal modifications during this treatment. Materials and methods: Forty-four newly diagnosed ALL children underwent bone measurement by QUS parameters BTT (Bone Transmission Time) and AD-SoS (Amplitude-Dependent Speed of Sound), mainly reliant on bone density and cortical thickness, respectively. Measurements were performed at diagnosis, and 6, 12, and 24 months thereafter. The occurrence of skeletal complications such as fractures, vertebral collapse, osteonecrosis, and osteopenia was related to measurement outcome. Results: A rapid deterioration of bone properties measured by Bit and AD-SoS was evident in the first semester of therapy (p<0.001). Subsequently, the next measurements were characterized by progressive uncoupling of the two QUS parameters (p<0.001). These were both significantly reduced at the end of therapy (p<0.001). Twelve subjects with in-treatment skeletal complications displayed an almost two-fold decrease of both parameters (p<0.001). Bit decreasing more than 1 Standard Deviation (SD) over 6 months of therapy was able to predict skeletal complication occurrence (p<0.001). Conclusion: This report represents the largest longitudinal cohort systematically submitted to bone condition assessment from the beginning to the end of therapy for childhood ALL. Bone deterioration occurs early and persists throughout therapy, consistent with bone properties uncoupling. This pattern possibly reflects an initial impairment of both mineral density and cortical thickness with a subsequent recovery of this latter. QUS permits an early detection of bone deterioration and related skeletal complications in childhood ALL. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1016 / 1020
页数:5
相关论文
共 50 条
  • [1] Letter to the editor in response to "Prospective bone ultrasound patterns during childhood acute lymphoblastic leukemia" by Mussa et al.
    Winkel, M. L. Te
    van der Sluis, I. M.
    Lequin, M. H.
    Pieters, R.
    van den Heuvel-Eibrink, M. M.
    BONE, 2010, 47 (04) : 835 - 836
  • [2] Abdominal ultrasound findings during and after treatment of childhood acute lymphoblastic leukemia
    Ojala, AE
    Lanning, FP
    Lanning, BM
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 29 (04): : 266 - 271
  • [3] Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia:: A prospective MRI study
    Ojala, AE
    Pääkkö, E
    Lanning, FP
    Lanning, M
    MEDICAL AND PEDIATRIC ONCOLOGY, 1999, 32 (01): : 11 - 17
  • [4] Bone mass after treatment for acute lymphoblastic leukemia in childhood
    Nysom, K
    Holm, K
    Hertz, H
    Müller, J
    Michaelsen, KF
    Molgaard, C
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) : 2970 - 2971
  • [5] Bone mass after treatment for acute lymphoblastic leukemia in childhood
    Nysom, K
    Holm, K
    Michaelsen, F
    Hertz, H
    Müller, J
    Molgaard, C
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3752 - 3760
  • [6] Bone mineral density (BMD) during treatment of childhood acute lymphoblastic leukemia (ALL)
    Bayer, M
    Stary, J
    Smisek, P
    Kutilek, S
    BONE, 2005, 36 : S76 - S76
  • [7] Bone mineral density in childhood acute lymphoblastic leukemia (ALL) during and after treatment
    van der Sluis, IM
    Keizer-Schrama, SMPFD
    van den Heuvel-Eibrink, MM
    PEDIATRIC BLOOD & CANCER, 2004, 43 (02) : 182 - 183
  • [8] Neuropathic Pain During Treatment for Childhood Acute Lymphoblastic Leukemia
    Anghelescu, Doralina L.
    Faughnan, Lane G.
    Jeha, Sima
    Relling, Mary V.
    Hinds, Pamela S.
    Sandlund, John T.
    Cheng, Cheng
    Pei, Deqing
    Hankins, Gisele
    Pauley, Jennifer L.
    Pui, Ching-Hon
    PEDIATRIC BLOOD & CANCER, 2011, 57 (07) : 1147 - 1153
  • [9] Treatment of Childhood Acute Lymphoblastic Leukemia
    Stanulla, Martin
    Schrappe, Martin
    SEMINARS IN HEMATOLOGY, 2009, 46 (01) : 52 - 63
  • [10] Treatment of Acute Lymphoblastic Leukemia in Childhood
    Schrappe, Martin
    ANNALS OF HEMATOLOGY, 2017, 96 : S35 - S36